Case guide

Roundup: Which Company and Claim Should Be Checked?

Ask which maker and legal duty fit the product you used. The 2026 ruling bars one cancer-label claim; it does not decide every possible case.

See If You Qualify

Free · No obligation · About 2 minutes

Updated Oct 4, 202615 sources

This may apply to you if

  • Review the exact product and exposure history.
  • Review the cancer diagnosis and date in the medical record.
  • Review earlier cases, releases and proposed class-program rules.

What the public record says

These are cited sources. Their inclusion does not imply that they endorse People’s Justice or reviewed this page.

International Agency for Research on Cancer · World Health Organization · Cancer agency issuing the March 2015 evaluation

Finding: The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.

IARC glyphosate evaluation, March 20, 2015 (opens in a new tab) · Mar 20, 2015 · Checked Oct 3, 2026

The evidence and its limits

National Cancer Institute and Agricultural Health Study collaborators · Journal of the National Cancer Institute · 2018

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

Design:
Cohort
Participants:
54,251 licensed pesticide applicators; 44,932 reported glyphosate use
Finding:
The cohort did not find an overall link between glyphosate use and non-Hodgkin lymphoma.
Main limitation
Exposure was self-reported in a specific work population. This observational result cannot decide what caused one person’s cancer.

Read the source: Glyphosate Use and Cancer Incidence in the Agricultural Health Study (opens in a new tab) · Checked Oct 3, 2026

International Agency for Research on Cancer, World Health Organization · 2015

IARC Monographs Volume 112 glyphosate evaluation

Design:
Agency review
Participants:
No single sample; review of human, animal and laboratory evidence
Finding:
The agency classified glyphosate as a probable human cancer hazard using limited human evidence and animal evidence.
Main limitation
Limited human evidence means other explanations for a link could not be ruled out. A hazard classification does not prove a personal cause.

Read the source: IARC Monographs Volume 112 glyphosate evaluation (opens in a new tab) · Checked Oct 3, 2026

The short answer

Why does the company named in a claim matter?
Ask which company and product your records identify. A claim needs facts about harm and who may be at fault. [1]
What did the Supreme Court decide in 2026?
It ruled that federal pesticide law bars Durnell’s claim requiring a cancer warning on the label. The decision was issued June 25, 2026. [1]
Does scientific evidence decide corporate liability?
A study or agency view does not decide a company’s duty to you. Each finding also has limits. [2]
Is the King proposal the same as a judgment?
A proposed deal needs a review of its own terms. It is not a court finding that the company caused each person’s harm. [7]

The process

What happens next

  1. 01

    You answer a few questions

    About two minutes. Nothing is sent until you agree on the last step and press submit.

  2. 02

    A lawyer looks at it

    A lawyer at the firm reads your answers and checks them against the current case criteria.

  3. 03

    The firm decides and gets in touch

    If the firm takes your case, you get the terms in writing to read before you sign. You can always say no.

Why does the company named in a claim matter?

Ask which company and product your records identify. A claim needs facts about harm and who may be at fault.

The Supreme Court opinion identifies Monsanto as the maker and seller in Durnell’s case. That caption does not list every party liable for each product. Keep your label and use dates. Ask a lawyer which company the records identify and what law applies to it.

What did the Supreme Court decide in 2026?

It ruled that federal pesticide law bars Durnell’s claim requiring a cancer warning on the label. The decision was issued June 25, 2026.

The Court reversed the Missouri judgment and sent the case back. This is a holding about the warning duty at issue; it is not a statement that no other claim can exist. Ask which alleged legal duty your own proposed case relies on and how the ruling affects it.

Does scientific evidence decide corporate liability?

A study or agency view does not decide a company’s duty to you. Each finding also has limits.

IARC’s view of cancer hazard differs from EPA’s view. A study of licensed pesticide users found no overall link with lymphoma. Both findings matter, with their limits. A lawyer still needs to check your product, harm, parties and claim.

Is the King proposal the same as a judgment?

A proposed deal needs a review of its own terms. It is not a court finding that the company caused each person’s harm.

The program notice describes a proposed deal and rules for who can join or be paid. It says the court will decide approval after the September 14 hearing. Ask for the latest court order before treating proposed terms as final. Keep any release you have signed.

What documents help identify the right claim?

Keep product labels, use dates, care records and any earlier legal notice. Ask what is missing before choosing a party or theory.

Patients generally can request covered medical and billing records, subject to exceptions and copying charges. Give the lawyer your actual product and health history. Ask how any earlier lawsuit or release affects the options, instead of assuming the current company name resolves historical responsibility.

What should I ask the firm before hiring it?

Ask about the legal duty, deadline and effect of any proposed release. Read the fee and expense terms before agreeing.

A time limit depends on the law and claim, not a company name alone. An agreed recovery share and separate case expenses can affect what you receive or owe. Ask who will handle the matter and who is responsible for checking dates and filing any required papers.

Scientific evidence for this case

Roundup lawsuit: who may qualify and what happens next · Mutation Research / Reviews in Mutation Research · 2019Meta-analysis

Exposure to Glyphosate-Based Herbicides and Risk for Non-Hodgkin Lymphoma: A Meta-Analysis

41% increased risk of NHL among highest-exposed individuals (OR = 1.41, 95% CI: 1.13-1.75)

Roundup lawsuit: who may qualify and what happens next · IARC Monographs on the Evaluation of Carcinogenic Risks to Humans · 2015Meta-analysis

IARC Monograph Volume 112: Glyphosate Evaluation

Classified glyphosate as Group 2A — "probably carcinogenic to humans"

Roundup lawsuit: who may qualify and what happens next · Journal of the National Cancer Institute · 2018Cohort

Glyphosate Use and Cancer Incidence in the Agricultural Health Study

No statistically significant overall association between glyphosate and NHL in the full cohort

Find out where you stand.

The review is free and private. Asking for it doesn’t commit you to anything.

Register your interest

Sources

  1. Supreme Court: Monsanto v. Durnell, June 25, 2026; checked 2026-10-03.Supreme Court: Monsanto v. Durnell, June 25, 2026 · court
  2. IARC glyphosate evaluation, March 20, 2015; checked 2026-10-03.IARC glyphosate evaluation, March 20, 2015
  3. Andreotti and colleagues: Agricultural Health Study; checked 2026-10-03.Andreotti and colleagues: Agricultural Health Study · study
  4. EPA: glyphosate review; checked 2026-10-03.EPA: glyphosate review · regulator
  5. King v. Monsanto preliminary approval order, March 4, 2026; checked 2026-10-03.King v. Monsanto preliminary approval order, March 4, 2026 · court
  6. King fairness hearing order, August 6, 2026; checked 2026-10-03.King fairness hearing order, August 6, 2026 · court
  7. Court-authorized Weed Killer Class notice and FAQs; checked 2026-10-03.Court-authorized Weed Killer Class notice and FAQs · court
  8. HHS: Your Medical Records; checked 2026-10-03.HHS: Your Medical Records · regulator
  9. Federal courts: civil cases; checked 2026-10-03.Federal courts: civil cases · court
  10. ABA: fees paid from a successful claim; checked 2026-10-03.ABA: fees paid from a successful claim
  11. SDNY: filing time limits; checked 2026-10-03.SDNY: filing time limits · court
  12. ABA Model Rule 1.5: fees; checked 2026-10-03.ABA Model Rule 1.5: fees
  13. JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026JPML Pending MDL Dockets by Actions Pending, Oct. 1, 2026 · court
  14. JPML Pending MDL Dockets by Actions Pending, July 1, 2026JPML Pending MDL Dockets by Actions Pending, July 1, 2026 · court
  15. JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026JPML Pending MDL Dockets by Actions Pending, Sept. 1, 2026 · court

Checked against 12 primary sources by People's Justice editors · Updated

How we make money

People's Justice research team · Updated Oct 4, 2026